4.6 Article

Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

Youchun Wang et al.

Summary: The Omicron variant shows greater potential for immune escape compared to other variants, suggesting a significant impact on immunity from previous infections and vaccines.

EMERGING MICROBES & INFECTIONS (2022)

Article Immunology

Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

Kelvin Kai-Wang To et al.

Summary: The study confirmed reinfection in an apparently immunocompetent patient 142 days after the first symptomatic episode, rather than persistent viral shedding. This suggests that SARS-CoV-2 may continue to circulate among humans, even with natural herd immunity, highlighting the need for further research on protective immunological correlates for vaccine design.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Genomic evidence for reinfection with SARS-CoV-2: a case study

Richard L. Tillett et al.

Summary: A man was infected with SARS-CoV-2 twice with genetically different virus variants, the second infection being more severe. The study suggests that previous exposure to SARS-CoV-2 may not guarantee immunity, and all individuals should take precautions to avoid infection. This has implications for vaccine development and application.

LANCET INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

A case of COVID-19 reinfection in the UK

Jack West et al.

Summary: This report describes the first published case in the UK of a person experiencing two distinct episodes of COVID-19 infection, with the second infection being milder and showing faster recovery. The individual was exposed to a high viral load prior to reinfection, posing challenges for public health and vaccination efforts.

CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS-CoV-2 infection

Charlotte Manisty et al.

Summary: This study found that post-SARS-CoV-2 infection, there are heterogeneous immune responses, with anti-S1 antibodies being cleared faster, transitioning more quickly to low levels of production, and experiencing greater reductions in production rate. In mild infections, relying solely on anti-S1 serology may underestimate the incidence of infections.

EBIOMEDICINE (2021)

Article Virology

Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases

Szilard Vancsa et al.

Summary: The second episode of SARS-CoV-2 positivity tends to be more severe if it occurs within 60 days after the first positive PCR. Younger patients are more predominant in the delayed recurrent positive group.

VIRUSES-BASEL (2021)

Article Virology

SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies

Thomas Theo Brehm et al.

Summary: Only a few reports on SARS-CoV-2 reinfections with limited immunological and virological data have been published. Our study found that a moderate immune response after the first infection, rather than viral escape, may lead to reinfection and live virus shedding.

VIRUSES-BASEL (2021)

Article Virology

Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort

Muneerah Smith et al.

Summary: The study demonstrated significant variations in the magnitude and epitope utilization of the humoral immune response to SARS-CoV-2 viral antigens within populations following natural infection, as shown through a novel protein microarray design.

VIRUSES-BASEL (2021)

Article Public, Environmental & Occupational Health

Emergency Department Visits for COVID-19 by Race and Ethnicity-13 States, October-December 2020

Amanda R. Smith et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Infectious Diseases

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection

Hari Ram Choudhary et al.

Summary: By following up with 76 individuals who tested positive for SARS-CoV-2 infection for 16 weeks, it was found that antibodies against nucleocapsid antigen protein showed a waning trend but did not completely disappear. Some individuals became seronegative in qualitative assays, yet all remained positive in quantitative testing.

INFECTION (2021)

Article Multidisciplinary Sciences

Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells

Kosuke Miyauchi et al.

Summary: This study reveals that influenza infection facilitates a broader antibody response by unmasking haemagglutinin epitopes and signaling IL-4 in the germinal center, shedding light on the differences in antibody responses induced by vaccination versus infection.

NATURE COMMUNICATIONS (2021)

Review Immunology

Breadth of Antibody Responses during Influenza Virus Infection and Vaccination

Masato Kubo et al.

TRENDS IN IMMUNOLOGY (2020)

Review Public, Environmental & Occupational Health

Racial and Gender-Based Differences in COVID-19

Jonathan Kopel et al.

FRONTIERS IN PUBLIC HEALTH (2020)

Letter Medicine, General & Internal

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19

F. Javier Ibarrondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Immunology

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus

Daniel C. Payne et al.

EMERGING INFECTIOUS DISEASES (2016)

Article Immunology

Duration of antibody responses after severe acute respiratory syndrome

Li-Ping Wu et al.

EMERGING INFECTIOUS DISEASES (2007)